Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Conyers

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
Nature Genetics|November 16, 2018
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeTenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Genetics|October 31, 2018
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeTenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Internal Medicine Journal|November 13, 2022
Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID-19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cellJacinta Perram, Duncan Purtill, Ashish Bajel, et al.
Internal Medicine Journal|December 17, 2019
The Australia and New Zealand Cardio-Oncology Registry: evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patientsDaniel Lapirow, Andre La Gerche, Claudia Toro, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
Nature Genetics|November 16, 2018
Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeTenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Genetics|October 31, 2018
Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeTenzin Gayden, Fernando E Sepulveda, Dong-Anh Khuong-Quang, et al.
Nature Communications|December 3, 2024
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 yearsMichelle A Neller, George R Ambalathingal, Nada Hamad, et al.
Pageof 7